Span Divergent Ltd
Incorporated in 1972, Span Divergent Ltd invests in Cashew Processing, Plant Tissue Culture and Trading of consumables used in Pharma/Biotech Industries.
- Market Cap ₹ 17.5 Cr.
- Current Price ₹ 32.0
- High / Low ₹ 45.3 / 12.9
- Stock P/E 19.4
- Book Value ₹ -3.22
- Dividend Yield 0.00 %
- ROCE 36.0 %
- ROE %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Earnings include an other income of Rs.1.77 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
81.23 | 81.03 | 75.47 | 0.00 | 2.87 | 14.57 | 24.14 | 9.38 | 7.40 | 13.09 | 12.52 | 12.33 | 12.55 | |
73.64 | 77.14 | 74.28 | 5.23 | 8.37 | 25.16 | 31.34 | 15.16 | 9.64 | 12.67 | 11.42 | 10.94 | 11.43 | |
Operating Profit | 7.59 | 3.89 | 1.19 | -5.23 | -5.50 | -10.59 | -7.20 | -5.78 | -2.24 | 0.42 | 1.10 | 1.39 | 1.12 |
OPM % | 9.34% | 4.80% | 1.58% | -191.64% | -72.68% | -29.83% | -61.62% | -30.27% | 3.21% | 8.79% | 11.27% | 8.92% | |
0.99 | 0.55 | 53.94 | 9.98 | 4.04 | 2.57 | -0.76 | 1.96 | 0.82 | -7.54 | -3.45 | 1.77 | 1.77 | |
Interest | 3.78 | 4.41 | 4.39 | 0.03 | 0.20 | 1.70 | 1.89 | 1.99 | 1.58 | 1.08 | 1.00 | 0.72 | 0.66 |
Depreciation | 3.12 | 4.85 | 5.96 | 0.18 | 0.82 | 2.60 | 3.62 | 3.45 | 3.11 | 2.17 | 2.17 | 1.64 | 1.23 |
Profit before tax | 1.68 | -4.82 | 44.78 | 4.54 | -2.48 | -12.32 | -13.47 | -9.26 | -6.11 | -10.37 | -5.52 | 0.80 | 1.00 |
Tax % | 80.36% | 30.29% | 12.93% | 27.97% | 5.24% | 1.46% | 4.31% | -7.02% | 0.82% | -2.12% | -1.81% | 2.50% | |
0.33 | -6.28 | 38.99 | 3.28 | -2.61 | -12.50 | -14.05 | -8.61 | -6.16 | -10.15 | -5.42 | 0.79 | 0.90 | |
EPS in Rs | 0.43 | -8.66 | 53.59 | 6.06 | -4.78 | -22.89 | -22.28 | -14.23 | -10.23 | -17.94 | -9.25 | 1.79 | 2.12 |
Dividend Payout % | 117.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -17% |
5 Years: | -13% |
3 Years: | 19% |
TTM: | -6% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | 15% |
3 Years: | 26% |
TTM: | 204% |
Stock Price CAGR | |
---|---|
10 Years: | -5% |
5 Years: | 18% |
3 Years: | 33% |
1 Year: | 129% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7.28 | 7.28 | 7.28 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 |
Reserves | 21.78 | 15.35 | 54.41 | 44.71 | 43.11 | 30.61 | 19.87 | 12.12 | 6.56 | -3.24 | -8.30 | -7.35 | -7.22 |
36.60 | 37.52 | 0.34 | 0.19 | 13.12 | 23.18 | 22.30 | 19.19 | 17.99 | 13.19 | 11.15 | 9.11 | 8.08 | |
23.43 | 29.38 | 3.80 | 0.44 | 2.97 | 4.02 | 1.64 | 2.56 | 4.27 | 12.27 | 17.02 | 16.64 | 17.01 | |
Total Liabilities | 89.09 | 89.53 | 65.83 | 50.80 | 64.66 | 63.27 | 49.27 | 39.33 | 34.28 | 27.68 | 25.33 | 23.86 | 23.33 |
36.65 | 41.26 | 2.20 | 2.15 | 8.15 | 25.91 | 22.47 | 20.19 | 17.72 | 15.36 | 13.12 | 10.75 | 9.92 | |
CWIP | 7.00 | 1.75 | 0.09 | 0.06 | 10.95 | 0.00 | 0.06 | 0.13 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 45.81 | 35.55 | 27.87 | 25.50 | 16.36 | 10.07 | 9.43 | 4.03 | 3.95 | 4.69 | 6.19 |
45.44 | 46.52 | 17.73 | 13.04 | 17.69 | 11.86 | 10.38 | 8.94 | 7.11 | 8.29 | 8.26 | 8.42 | 7.22 | |
Total Assets | 89.09 | 89.53 | 65.83 | 50.80 | 64.66 | 63.27 | 49.27 | 39.33 | 34.28 | 27.68 | 25.33 | 23.86 | 23.33 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
7.89 | 8.21 | 60.91 | -7.36 | -5.38 | -11.74 | -7.09 | -0.12 | -0.21 | 7.03 | 1.98 | 2.50 | |
-12.63 | -4.80 | -12.13 | 13.39 | -5.55 | 0.81 | 10.05 | 5.89 | 1.99 | -2.05 | 0.53 | 0.12 | |
4.31 | -3.90 | -42.19 | -12.17 | 12.74 | 7.37 | -2.82 | -7.32 | -1.41 | -5.50 | -2.30 | -2.09 | |
Net Cash Flow | -0.43 | -0.49 | 6.59 | -6.13 | 1.80 | -3.57 | 0.14 | -1.55 | 0.37 | -0.52 | 0.20 | 0.53 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 90.00 | 82.07 | 3.72 | 1.27 | 59.62 | 22.08 | 39.30 | 73.49 | 44.06 | 55.39 | 45.88 | |
Inventory Days | 166.50 | 189.41 | 2.68 | 314.18 | 101.31 | 52.17 | 83.88 | 143.23 | 179.48 | 317.65 | 206.08 | |
Days Payable | 59.78 | 116.44 | 1.17 | 78.54 | 39.95 | 12.44 | 79.35 | 298.01 | 213.76 | 526.78 | 480.26 | |
Cash Conversion Cycle | 196.72 | 155.05 | 5.24 | 236.90 | 120.98 | 61.81 | 43.84 | -81.29 | 9.77 | -153.74 | -228.30 | |
Working Capital Days | 61.42 | 18.51 | -7.01 | 133.54 | 113.73 | 19.96 | 14.01 | -108.51 | -241.20 | -430.01 | -446.41 | |
ROCE % | 8.89% | -0.64% | -4.35% | -5.73% | -8.98% | -19.95% | -19.10% | -19.87% | -15.86% | -3.67% | -9.50% | 36.03% |
Documents
Announcements
-
Closure of Trading Window
15h - Closure of trading window for designated persons.
-
Span Divergent Limited-Intimation Regarding Temporary Halt Of The Manufacturing Operations Of Subsidiary
9 Dec - Temporary halt of manufacturing at DRYFRUIT FACTORY LLP.
-
Span Divergent Limited-Intimation Regarding Temporary Halt Of The Manufacturing Operations Of Subsidiary
9 Dec - Temporary halt of manufacturing operations at subsidiary.
-
Span Divergent Limited-Intimation Regarding Temporary Halt Of The Manufacturing Operations Of Subsidiary
6 Dec - Temporary halt of manufacturing at DRYFRUIT FACTORY LLP.
-
Board Meeting Outcome for Revised Outcome
29 Oct - Board approved unaudited financial results for Q2 FY2024-25.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Services Offered:[1]
Company is operating in various businesses through specific subsidiary firm formed for each of the businesses.
a) Dryfruit Factory LLP (DFFL):
Company has a plant near Ahmedabad for processing of Raw Cashew Nuts (RCNs) into a finished cashew. Its commercial production
started in Q2FY18
b) Aranya Agri Biotech LLP (AABL):
It is involved in Plant Tissue Culture business which falls into Agriculture Activities. It is also doing Research and Development to make new products which can be cultivated through tissue culture techniques
c) Desai Farmharvest LLP:
No operation has started in this LLP
d) Biospan Scientific LLP (BSLLP):
This focuses on areas of Microbiology, Protein research and Scientific Laboratory products. As of now, LLP has limited products under its name.
e) Biospan Contamination Control Solutions Private Limited (BSCCS):
BSCCS is a joint venture formed between Span Divergent Ltd. and Micronclean UK, with Span having 67% equity stake. It caters to Pharma along with Biotechnology industry having clean room consumable requirement. Products are imported from Joint Venture Partner Company from UK and other reputed companies world-wide operating in similar segment.
f) Span Diagnostics LLP:
No operation has started in this LLP
g) Span Diagnostics South Africa (PTY) Limited:
Being an inoperative entity, company has initiated process either to divest its investment from this venture or close down the same.